Appendix 3 and 4

Total Page:16

File Type:pdf, Size:1020Kb

Appendix 3 and 4 Appendix 3 : Conserved proteins present in L. interrogans serovar Canicola L. interrogans serovar Canicola Accession Number Protein identification Protein Length (Amino Acids) Mean No. of peptides Mean % Coverage 5,10 methylene tetrahydrofolate 45655587 310 7.67 11.33 reductase 45655588 274 hypothetical protein LIC20005 4.33 20.00 45655592 547 porphobilinogen deaminase 4.33 7.67 delta-aminolevulinic acid 45655593 317 15.00 20.33 dehydratase glutamate-1-semialdehyde 45655594 443 24.00 24.33 aminotransferase 45655597 340 uroporphyrinogen decarboxylase 2.67 5.67 45655598 443 coproporphyrinogen III oxidase 5.00 12.33 45655605 200 azoreductase 5.33 18.00 45655609 251 short-chain dehydrogenase 2.33 14.33 45655611 422 NADH dehydrogenase 3.67 11.00 45655613 202 hypothetical protein LIC20030 2.33 15.67 45655615 140 hypothetical protein LIC20032 4.33 15.67 45655617 356 hypothetical protein LIC20034 2.33 8.33 45655618 440 hypothetical protein LIC20035 8.17 14.67 methanol dehydrogenase 45655620 357 7.83 19.17 regulator 45655627 607 heat shock protein 90 9.33 14.83 45655628 189 hypothetical protein LIC20045 2.33 8.33 45655641 670 methylmalonyl-CoA mutase 14.33 14.33 phosphoribosyl-ATP 45655645 92 10.67 13.00 pyrophosphatase 3-oxoacyl-(acyl-carrier protein) 45655647 254 4.00 17.00 reductase 45655648 77 acyl carrier protein 3.67 9.00 45655661 171 hypothetical protein LIC20078 5.00 26.00 4-hydroxybenzoyl-CoA 45655663 142 3.33 11.67 thioesterase S-adenosyl-L-homocysteine 45655666 436 13.00 19.67 hydrolase B12-dependent methionine 45655668 1247 42.67 21.67 synthase diphosphate--fructose-6- 45655671 431 3.33 7.33 phosphate 1-phosphotransferase bacterioferritin comigratory 45655676 163 5.00 23.67 protein 45655679 365 hypothetical protein LIC20096 6.33 13.33 45655680 270 short-chain dehydrogenase 2.67 13.67 45655683 283 hypothetical protein LIC20100 2.00 11.67 45655685 408 pheromone shutdown protein 5.67 15.67 45655691 132 anti-sigma factor antagonist 5.83 18.33 45655697 363 LipL45 homologue 4.00 9.67 capsular polysaccharide 45655720 629 3.83 7.33 biosynthesis protein 45655723 295 heat shock protein HtpX 4.33 13.67 adenine 45655724 177 13.33 21.00 phosphoribosyltransferase 45655725 504 HtrA1 4.67 8.50 45655726 527 HtrA1-like protein 4.33 10.67 45655728 525 hypothetical protein LIC20146 2.67 5.33 45655740 540 ATP-dependent protease 3.33 6.00 45655747 386 hypothetical protein LIC20165 5.83 11.83 45655749 356 hypothetical protein LIC20167 7.00 14.00 45655754 717 lipoprotein 2.67 3.33 45655757 150 dnaK suppressor 7.67 29.00 45655767 233 hypothetical protein LIC20185 10.33 33.00 45655772 485 hypothetical protein LIC20190 4.00 8.67 4-hydroxybutyrate CoA 45655775 429 3.00 8.67 transferase 45655776 172 hypothetical protein LIC20196 5.33 16.67 45655777 799 cysteine protease 25.67 22.33 UTP-glucose-1-phosphate 45655779 472 4.67 9.67 uridyltransferase 45655784 383 cysteine desulfurase 10.00 11.00 45655785 289 hypothetical protein LIC20205 4.33 13.33 methylmalonyl-COA mutase 45655788 626 12.33 18.33 small subunit 45655789 732 methylmalonyl-CoA mutase 23.00 20.33 45655794 843 hypothetical protein LIC20214 3.00 6.00 45655796 204 ExbB 3.33 14.17 45655803 143 hypothetical protein LIC20223 17.00 11.00 3-oxoacyl-[acyl-carrier protein] 45655805 232 5.67 17.33 reductase acireductone dioxygenase 45655807 177 9.33 36.00 enzyme ARD and ARD' phosphate ABC transporter 45655808 299 periplasmic phosphate-binding 2.33 9.67 protein S-adenosylmethionine 45655814 288 3.67 15.00 decarboxylase like protein 45655816 180 hypothetical protein LIC20240 4.67 19.33 45655817 389 alanine racemase 13.67 28.33 45655818 381 putative acyltransferase 6.33 14.33 45655819 303 hypothetical protein LIC20243 6.50 18.83 45655822 771 histidine kinase sensor protein 3.17 5.50 45655824 757 aconitate hydratase 19.00 16.00 peptidoglycan-associated 45655825 383 6.00 18.33 cytoplasmic membrane protein 45655829 243 response regulator 13.33 37.33 45655839 486 pyruvate kinase 6.67 16.00 aspartate-semialdehyde 45655841 349 7.50 17.00 dehydrogenase 45655847 357 hypothetical protein LIC20272 5.17 13.50 45655849 250 hypothetical protein LIC20274 3.50 16.17 45655850 281 hypothetical protein LIC20275 5.67 19.33 45655851 312 hypothetical protein LIC20276 2.67 4.00 chromosomal replication initiator 45655915 443 2.33 4.67 protein 45655916 373 DNA polymerase III beta subunit 16.00 24.33 45655919 639 DNA gyrase subunit B 15.33 17.67 45655920 834 DNA gyrase subunit A 14.00 14.00 45655923 245 putative lipoprotein 7.33 31.00 45655925 186 LipL21 3.00 11.00 45655931 301 hypothetical protein LIC10017 4.50 10.00 3-oxoacyl-acyl carrier protein 45655933 247 9.67 29.33 reductase 45655934 202 hypothetical protein LIC10020 3.67 19.00 45655936 120 arsenate reductase 3.00 23.00 45655941 234 hypothetical protein LIC10027 13.50 13.83 45655943 282 inositol monophosphatase 7.33 20.00 45655949 751 ribonuclease R 2.00 2.67 45655951 537 GMC oxidoreductase 4.00 9.00 45655952 502 hypothetical protein LIC10038 3.83 7.00 45655953 234 3-dehydroquinate dehydratase 2.33 10.00 45655959 312 dTDP-glucose 4-6-dehydratase 13.33 27.67 proton-translocating 45655960 389 transhydrogenase, subunit alpha 15.33 36.17 part 1 45655962 439 histidyl-tRNA synthetase 19.67 18.33 peptidoglycan-associated 45655964 687 2.83 2.50 cytoplasmic membrane protein 45655974 1061 hypothetical protein LIC10060 4.00 4.00 45655978 160 hypothetical protein LIC10064 4.33 9.00 deoxycytidine triphosphate 45655979 173 4.00 27.67 deaminase enoyl-CoA hydratase/isomerase 45655980 260 4.33 22.00 family protein 45655983 132 glyoxylase I 14.00 38.33 3-demethylubiquinone-9 3- 45655987 283 3.67 17.00 methyltransferase 45655988 281 diaminopimelate epimerase 11.67 26.00 45655997 415 RNA methyltransferase 2.00 5.33 45656005 685 long-chain-fatty-acid CoA ligase 9.33 14.67 45656006 118 hypothetical protein LIC10095 12.83 17.00 45656012 500 cystathionine gamma-synthase 10.33 19.00 45656016 340 hypothetical protein LIC10105 6.33 23.33 imidazoleglycerol-phosphate 45656022 206 2.33 8.67 dehydratase phosphoribosylformimino-5- 45656024 241 aminoimidazole carboxamide 4.67 23.33 ribotide isomerase protein 45656025 404 hypothetical protein LIC10115 5.17 15.00 45656027 616 hypothetical protein LIC10117 5.33 9.33 phoshomethylpyrimidine kinase 45656028 273 8.00 17.67 protein 45656032 433 hypothetical protein LIC10122 11.33 13.67 45656033 330 LipL45-like protein 4.00 10.33 45656034 551 hypothetical protein LIC10124 22.00 21.50 45656035 1197 hypothetical protein LIC10125 10.67 8.67 45656037 312 hypothetical protein LIC10127 4.33 9.33 45656042 699 sigma 54 activator 7.83 9.83 45656044 408 hypothetical protein LIC10134 3.50 9.17 45656045 132 SET domain-containing protein 9.00 26.33 HD-GYP hydrolase domain- 45656048 489 5.17 8.33 containing protein 45656050 380 chorismate synthase 6.00 18.00 NADH dehydrogenase I G 45656051 482 4.67 10.00 subunit 45656052 175 NADH dehydrogenase I I subunit 4.00 16.00 45656055 457 hypothetical protein LIC10145 4.00 6.33 45656063 627 hypothetical protein LIC10157 6.33 8.17 45656064 236 hypothetical protein LIC10158 7.17 17.17 45656066 437 malic enzyme 3.67 11.00 45656067 699 hypothetical protein LIC10161 3.50 4.67 45656068 464 fumarate hydratase 17.00 29.33 45656074 132 hypothetical protein LIC10168 2.67 18.67 45656081 495 hypothetical protein LIC10175 3.00 5.33 peptidoglycan associated 45656096 195 14.00 46.00 cytoplasmic membrane protein 45656103 271 inositol monophosphatase 3.33 11.00 cytochrome c oxidase 45656113 333 11.50 23.83 polypeptide II cytochrome c oxidase 45656114 534 3.67 3.67 polypeptide I 45656116 99 hypothetical protein LIC10211 3.00 24.67 45656119 197 CarD transcriptional regulator 3.67 18.33 45656120 343 hypothetical protein LIC10215 11.50 22.00 phosphoenolpyruvate 45656121 530 62.33 34.00 carboxykinase aspartyl/glutamyl-tRNA 45656126 486 8.33 15.33 amidotransferase subunit B 45656131 242 hypothetical protein LIC10226 8.67 23.67 45656132 609 hypothetical protein LIC10227 3.00 5.00 45656136 337 hypothetical protein LIC10231 2.83 10.33 lipoprotein releasing system 45656137 458 3.33 6.67 transmembrane protein 45656140 94 hypothetical protein LIC10235 3.00 13.00 45656142 405 cyclic nucleotide binding protein 6.17 16.17 45656146 231 hypothetical protein LIC10241 9.67 19.33 45656158 417 alcohol dehydrogenase 23.67 29.00 45656162 182 MutT/nudix family protein 2.67 13.67 45656172 221 cyclic nucleotide binding protein 5.17 13.50 45656173 351 cyclic nucleotide binding protein 4.00 12.33 45656174 416 chlorohydrolase family protein 2.67 9.33 45656176 706 elongation factor G 45.67 25.33 zinc-binding dehydrogenase 45656186 340 7.67 25.67 family protein 45656187 332 farnesyl-diphosphate synthase 3.33 8.67 H+-translocating 45656194 466 6.00 12.00 transhydrogenase subunit beta glycerophosphoryl diester 45656197 331 6.33 21.00 phosphodiesterase 45656206 349 hypothetical protein LIC10302 2.67 8.33 45656213 964 glycine dehydrogenase 11.00 10.00 45656218 557 hypothetical protein LIC10314 22.83 20.33 45656221 145 ribose 5-phosphate isomerase B 5.00 31.00 45656222 640 hypothetical protein LIC10318 3.50 4.67 45656225 696 hypothetical protein LIC10321 2.67 3.67 45656229 378 hemolysin 3.33 11.33 45656230 524 hypothetical protein LIC10326 3.67 8.00 45656241 369 hypothetical protein LIC10337 2.67 11.00 45656243 846 hemolysin B 17.50 18.17 45656253 160 hypothetical protein LIC10350 3.00 15.00 ABC transporter ATP-binding 45656254 304 2.67 9.33 protein 45656256 503 hypothetical protein LIC10353 3.00 4.33 45656260 322 tryptophanyl-tRNA synthetase 7.00 14.00 electron transfer flavoprotein
Recommended publications
  • A Putative Cystathionine Beta-Synthase Homolog of Mycolicibacterium Smegmatis Is Involved in De Novo Cysteine Biosynthesis
    University of Arkansas, Fayetteville ScholarWorks@UARK Theses and Dissertations 5-2020 A Putative Cystathionine Beta-Synthase Homolog of Mycolicibacterium smegmatis is Involved in de novo Cysteine Biosynthesis Saroj Kumar Mahato University of Arkansas, Fayetteville Follow this and additional works at: https://scholarworks.uark.edu/etd Part of the Cell Biology Commons, Molecular Biology Commons, and the Pathogenic Microbiology Commons Citation Mahato, S. K. (2020). A Putative Cystathionine Beta-Synthase Homolog of Mycolicibacterium smegmatis is Involved in de novo Cysteine Biosynthesis. Theses and Dissertations Retrieved from https://scholarworks.uark.edu/etd/3639 This Thesis is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more information, please contact [email protected]. A Putative Cystathionine Beta-Synthase Homolog of Mycolicibacterium smegmatis is Involved in de novo Cysteine Biosynthesis A thesis submitted in partial fulfillment of the requirement for the degree of Master of Science in Cell and Molecular Biology by Saroj Kumar Mahato Purbanchal University Bachelor of Science in Biotechnology, 2016 May 2020 University of Arkansas This thesis is approved for recommendation to the Graduate Council. ___________________________________ Young Min Kwon, Ph.D. Thesis Director ___________________________________ ___________________________________ Suresh Thallapuranam, Ph.D. Inés Pinto, Ph.D. Committee Member Committee Member ABSTRACT Mycobacteria include serious pathogens of humans and animals. Mycolicibacterium smegmatis is a non-pathogenic model that is widely used to study core mycobacterial metabolism. This thesis explores mycobacterial pathways of cysteine biosynthesis by generating and study of genetic mutants of M. smegmatis. Published in vitro biochemical studies had revealed three independent routes to cysteine synthesis in mycobacteria involving separate homologs of cysteine synthase, namely CysK1, CysK2, and CysM.
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Pseudouridine Synthase 1: a Site-Specific Synthase Without Strict Sequence Recognition Requirements Bryan S
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Published online 18 November 2011 Nucleic Acids Research, 2012, Vol. 40, No. 5 2107–2118 doi:10.1093/nar/gkr1017 Pseudouridine synthase 1: a site-specific synthase without strict sequence recognition requirements Bryan S. Sibert and Jeffrey R. Patton* Department of Pathology, Microbiology and Immunology, University of South Carolina, School of Medicine, Columbia, SC 29208 USA Received May 20, 2011; Revised October 19, 2011; Accepted October 22, 2011 ABSTRACT rRNA and snRNA and requires Dyskerin or its homologs Pseudouridine synthase 1 (Pus1p) is an unusual (Cbf5p in yeast for example) and RNP cofactors [most site-specific modification enzyme in that it can often H/ACA small nucleolar ribonucleoprotein particles modify a number of positions in tRNAs and can rec- (snoRNPs)] that enable one enzyme to recognize many ognize several other types of RNA. No consensus different sites for modification on different substrates recognition sequence or structure has been identi- (17–25). The other pathway for É formation employs fied for Pus1p. Human Pus1p was used to determine site-specific É synthases that require no cofactors to rec- which structural or sequence elements of human ognize and modify the RNA substrate. A number of en- tRNASer are necessary for pseudouridine ()) forma- zymes have been identified in this pathway and are grouped in six families that all share a common basic tion at position 28 in the anticodon stem-loop (ASL). Ser structure (4). It is safe to say the cofactor ‘guided’ pathway Some point mutations in the ASL stem of tRNA has received a great deal of attention because of its simi- had significant effects on the levels of modification larity to aspects of RNA editing, but the site-specific and compensatory mutation, to reform the base pseudouridine synthases accomplish the same task, on pair, restored a wild-type level of ) formation.
    [Show full text]
  • Proteome Cold-Shock Response in the Extremely Acidophilic Archaeon, Cuniculiplasma Divulgatum
    microorganisms Article Proteome Cold-Shock Response in the Extremely Acidophilic Archaeon, Cuniculiplasma divulgatum Rafael Bargiela 1 , Karin Lanthaler 1,2, Colin M. Potter 1,2 , Manuel Ferrer 3 , Alexander F. Yakunin 1,2, Bela Paizs 1,2, Peter N. Golyshin 1,2 and Olga V. Golyshina 1,2,* 1 School of Natural Sciences, Bangor University, Deiniol Rd, Bangor LL57 2UW, UK; [email protected] (R.B.); [email protected] (K.L.); [email protected] (C.M.P.); [email protected] (A.F.Y.); [email protected] (B.P.); [email protected] (P.N.G.) 2 Centre for Environmental Biotechnology, Bangor University, Deiniol Rd, Bangor LL57 2UW, UK 3 Systems Biotechnology Group, Department of Applied Biocatalysis, CSIC—Institute of Catalysis, Marie Curie 2, 28049 Madrid, Spain; [email protected] * Correspondence: [email protected]; Tel.: +44-1248-388607; Fax: +44-1248-382569 Received: 27 April 2020; Accepted: 15 May 2020; Published: 19 May 2020 Abstract: The archaeon Cuniculiplasma divulgatum is ubiquitous in acidic environments with low-to-moderate temperatures. However, molecular mechanisms underlying its ability to thrive at lower temperatures remain unexplored. Using mass spectrometry (MS)-based proteomics, we analysed the effect of short-term (3 h) exposure to cold. The C. divulgatum genome encodes 2016 protein-coding genes, from which 819 proteins were identified in the cells grown under optimal conditions. In line with the peptidolytic lifestyle of C. divulgatum, its intracellular proteome revealed the abundance of proteases, ABC transporters and cytochrome C oxidase. From 747 quantifiable polypeptides, the levels of 582 proteins showed no change after the cold shock, whereas 104 proteins were upregulated suggesting that they might be contributing to cold adaptation.
    [Show full text]
  • TITLE PAGE Oxidative Stress and Response to Thymidylate Synthase
    Downloaded from molpharm.aspetjournals.org at ASPET Journals on October 2, 2021 -Targeted -Targeted 1 , University of of , University SC K.W.B., South Columbia, (U.O., Carolina, This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted.
    [Show full text]
  • Supplemental Methods
    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Structure of Soybean Serine Acetyltransferase
    THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 288, NO. 51, pp. 36463–36472, December 20, 2013 Published in the U.S.A. Structure of Soybean Serine Acetyltransferase and Formation of the Cysteine Regulatory Complex as a Molecular Chaperone* Received for publication, October 14, 2013, and in revised form, November 4, 2013 Published, JBC Papers in Press, November 13, 2013, DOI 10.1074/jbc.M113.527143 Hankuil Yi‡1, Sanghamitra Dey§1, Sangaralingam Kumaran¶, Soon Goo Leeʈ, Hari B. Krishnan**, and Joseph M. Jezʈ2 From the ‡Department of Biological Sciences, Chungnam National University, 220 Gung-Dong, Yuseong-Gu, Daejeon 305-764,Korea, the §Department of Biological Sciences, Presidency University, Kolkata, West Bengal 700073, India, the ¶Council of Scientific and Industrial Research, Institute of Microbial Technology, Sector 39-A, Chandigarh 160036, India, the ʈDepartment of Biology, Washington University, St. Louis, Missouri 63130, and the **Plant Genetics Research Unit, United States Department of Agriculture- Agricultural Research Service, Department of Agronomy, University of Missouri, Columbia, Missouri 65211 Background: Serine acetyltransferase (SAT) catalyzes the limiting step in cysteine biosynthesis. Results: Analysis of soybean SAT provides insight into catalysis and protein-protein interactions. Downloaded from Conclusion: Key structural features are required for catalysis and formation of a stable macromolecular complex. Significance: A new role for protein complex formation in plant cysteine biosynthesis is proposed. Serine acetyltransferase (SAT) catalyzes the limiting reaction sis plays a central role in fixing inorganic sulfur from the envi- in plant and microbial biosynthesis of cysteine. In addition to its ronment into the metabolic precursor for cellular thiol-con- http://www.jbc.org/ enzymatic function, SAT forms a macromolecular complex with taining compounds (3–6).
    [Show full text]
  • Letters to Nature
    letters to nature Received 7 July; accepted 21 September 1998. 26. Tronrud, D. E. Conjugate-direction minimization: an improved method for the re®nement of macromolecules. Acta Crystallogr. A 48, 912±916 (1992). 1. Dalbey, R. E., Lively, M. O., Bron, S. & van Dijl, J. M. The chemistry and enzymology of the type 1 27. Wolfe, P. B., Wickner, W. & Goodman, J. M. Sequence of the leader peptidase gene of Escherichia coli signal peptidases. Protein Sci. 6, 1129±1138 (1997). and the orientation of leader peptidase in the bacterial envelope. J. Biol. Chem. 258, 12073±12080 2. Kuo, D. W. et al. Escherichia coli leader peptidase: production of an active form lacking a requirement (1983). for detergent and development of peptide substrates. Arch. Biochem. Biophys. 303, 274±280 (1993). 28. Kraulis, P.G. Molscript: a program to produce both detailed and schematic plots of protein structures. 3. Tschantz, W. R. et al. Characterization of a soluble, catalytically active form of Escherichia coli leader J. Appl. Crystallogr. 24, 946±950 (1991). peptidase: requirement of detergent or phospholipid for optimal activity. Biochemistry 34, 3935±3941 29. Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and (1995). the thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11, 281±296 (1991). 4. Allsop, A. E. et al.inAnti-Infectives, Recent Advances in Chemistry and Structure-Activity Relationships 30. Meritt, E. A. & Bacon, D. J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505± (eds Bently, P. H. & O'Hanlon, P. J.) 61±72 (R. Soc. Chem., Cambridge, 1997).
    [Show full text]
  • Product Sheet Info
    Product Information Sheet for NR-19703 Vibrio cholerae Gateway® Clone Set, Growth Conditions: Media: Recombinant in Escherichia coli, Plate 25 LB broth or agar containing 50 µg/mL kanamycin Incubation: Catalog No. NR-19703 Temperature: E. coli, strain DH10B-T1 clones should be This reagent is the tangible property of the U.S. Government. grown at 37°C. Atmosphere: Aerobic For research use only. Not for human use. Propagation: 1. Scrape top of frozen well with a pipette tip and streak onto Contributor: agar plate. Pathogen Functional Genomics Resource Center at the J. 2. Incubate the plates at 37°C for 1 day. Craig Venter Institute Citation: Manufacturer: Acknowledgment for publications should read “The following BEI Resources reagent was obtained through BEI Resources, NIAID, NIH: ® Vibrio cholerae Gateway Clone Set, Recombinant in Product Description: Escherichia coli, Plate 25, NR-19703.” Production in the 96-well format has increased risk of cross- contamination between adjacent wells. Individual clones Biosafety Level: 1 should be purified (e.g. single colony isolation and purification Appropriate safety procedures should always be used with this using good microbiological practices) and sequence-verified material. Laboratory safety is discussed in the following prior to use. BEI Resources does not confirm or validate publication: U.S. Department of Health and Human Services, individual mutants provided by the contributor. Public Health Service, Centers for Disease Control and Prevention, and National Institutes of Health. Biosafety in The Vibrio cholerae (V. cholerae) Gateway® clone set consists Microbiological and Biomedical Laboratories. 5th ed. of 46 plates which contain 3813 sequence validated clones Washington, DC: U.S.
    [Show full text]
  • Figure S1. HAEC ROS Production and ML090 NOX5-Inhibition
    Figure S1. HAEC ROS production and ML090 NOX5-inhibition. (a) Extracellular H2O2 production in HAEC treated with ML090 at different concentrations and 24 h after being infected with GFP and NOX5-β adenoviruses (MOI 100). **p< 0.01, and ****p< 0.0001 vs control NOX5-β-infected cells (ML090, 0 nM). Results expressed as mean ± SEM. Fold increase vs GFP-infected cells with 0 nM of ML090. n= 6. (b) NOX5-β overexpression and DHE oxidation in HAEC. Representative images from three experiments are shown. Intracellular superoxide anion production of HAEC 24 h after infection with GFP and NOX5-β adenoviruses at different MOIs treated or not with ML090 (10 nM). MOI: Multiplicity of infection. Figure S2. Ontology analysis of HAEC infected with NOX5-β. Ontology analysis shows that the response to unfolded protein is the most relevant. Figure S3. UPR mRNA expression in heart of infarcted transgenic mice. n= 12-13. Results expressed as mean ± SEM. Table S1: Altered gene expression due to NOX5-β expression at 12 h (bold, highlighted in yellow). N12hvsG12h N18hvsG18h N24hvsG24h GeneName GeneDescription TranscriptID logFC p-value logFC p-value logFC p-value family with sequence similarity NM_052966 1.45 1.20E-17 2.44 3.27E-19 2.96 6.24E-21 FAM129A 129. member A DnaJ (Hsp40) homolog. NM_001130182 2.19 9.83E-20 2.94 2.90E-19 3.01 1.68E-19 DNAJA4 subfamily A. member 4 phorbol-12-myristate-13-acetate- NM_021127 0.93 1.84E-12 2.41 1.32E-17 2.69 1.43E-18 PMAIP1 induced protein 1 E2F7 E2F transcription factor 7 NM_203394 0.71 8.35E-11 2.20 2.21E-17 2.48 1.84E-18 DnaJ (Hsp40) homolog.
    [Show full text]
  • Granny Smith
    www.nature.com/scientificreports OPEN Ethylene –dependent and –independent superfcial scald resistance mechanisms in ‘Granny Received: 19 March 2018 Accepted: 17 July 2018 Smith’ apple fruit Published: xx xx xxxx Evangelos Karagiannis1, Michail Michailidis1, Georgia Tanou1,2, Martina Samiotaki3, Katerina Karamanoli4, Evangelia Avramidou5, Ioannis Ganopoulos6, Panagiotis Madesis7 & Athanassios Molassiotis 1 Superfcial scald is a major physiological disorder of apple fruit (Malus domestica Borkh.) characterized by skin browning following cold storage; however, knowledge regarding the downstream processes that modulate scald phenomenon is unclear. To gain insight into the mechanisms underlying scald resistance, ‘Granny Smith’ apples after harvest were treated with diphenylamine (DPA) or 1-methylcyclopropene (1-MCP), then cold stored (0 °C for 3 months) and subsequently were ripened at room temperature (20 °C for 8 days). Phenotypic and physiological data indicated that both chemical treatments induced scald resistance while 1-MCP inhibited the ethylene-dependent ripening. A combination of multi-omic analysis in apple skin tissue enabled characterization of potential genes, proteins and metabolites that were regulated by DPA and 1-MCP at pro-symptomatic and scald- symptomatic period. Specifcally, we characterized strata of scald resistance responses, among which we focus on selected pathways including dehydroabietic acid biosynthesis and UDP-D-glucose regulation. Through this approach, we revealed scald-associated transcriptional, proteomic and metabolic signatures and identifed pathways modulated by the common or distinct functions of DPA and 1-MCP. Also, evidence is presented supporting that cytosine methylation-based epigenetic regulation is involved in scald resistance. Results allow a greater comprehension of the ethylene– dependent and –independent metabolic events controlling scald resistance.
    [Show full text]